The importance of hepatic resection for hepatocellular carcinoma originating from nonfibrotic liver

被引:46
作者
Shimada, M
Rikimaru, T
Sugimachi, K
Hamatsu, T
Yamashita, Y
Aishima, S
Taguchi, K
Tanaka, S
Shirabe, K
Sugimachi, K
机构
[1] Kyushu Univ, Fac Med, Dept Surg 2, Higashi Ku, Fukuoka 8128582, Japan
[2] Kyushu Univ, Fac Med, Dept Pathol 2, Fukuoka 8128582, Japan
关键词
D O I
10.1016/S1072-7515(00)00705-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Our study aimed to clarify the characteristics of hepatocellular carcinoma (HCC) in patients with a nonfibrotic liver and the role of surgical resection for HCC in nonfibrotic liver compared with patients with HCC in fibrotic or cirrhotic livers. Study Design: A total of 516 patients who underwent hepatectomy between April 1985 and June 1999 were classified into two groups: a nonfibrotic liver group (n=65) and a fibrotic liver group (n=451), which included fibrotic or cirrhotic livers. Clinicopathologic variables were then compared between the groups, including disease-free survival rate and patient survival rate. Results: Only 8 of 65 patients (12.3%) with a nonfibrotic liver showed a histologically completely normal liver. The numbers of men and patients with alcohol abuse in the nonfibrotic liver group were higher than in the fibrotic liver group. The numbers of patients with positive hepatitis B antigen and positive hepatitis C antibody in the nonfibrotic liver group were lower than in the fibrotic liver group. Results of liver function tests in the nonfibrotic liver group were better than those in the fibrotic liver group. The rates of both portal vein and hepatic vein invasion of cancer cells in the nonfibrotic liver group were higher than in the fibrotic liver group. The tumor size in the nonfibrotic liver group was larger than in the fibrotic liver group. The patient survival and disease-free survival rates in the nonfibrotic liver group were better than in the fibrotic liver group. Conclusions: Hepatic resection can be beneficial for patients with HCC originating from a nonfibrotic liver when compared with fibrotic or cirrhotic patients with HCC. (J Am Coll Surg 2000;191:531-537. (C) 2000 by the American College of Surgeons).
引用
收藏
页码:531 / 537
页数:7
相关论文
共 33 条
[1]  
ALPERT ME, 1971, CANCER, V28, P253, DOI 10.1002/1097-0142(197107)28:1&lt
[2]  
253::AID-CNCR2820280151&gt
[3]  
3.0.CO
[4]  
2-G
[5]   Prevalence of the haemochromatosis gene mutation in non-cirrhotic liver with hepatocellular carcinoma [J].
Bralet, MP ;
Degott, C ;
Belghiti, J ;
Terris, B .
JOURNAL OF HEPATOLOGY, 1998, 28 (04) :740-740
[6]  
DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629
[7]   PRENEOPLASTIC SIGNIFICANCE OF HEPATIC IRON-FREE FOCI IN GENETIC HEMOCHROMATOSIS - A STUDY OF 185 PATIENTS [J].
DEUGNIER, YM ;
CHARALAMBOUS, P ;
LEQUILLEUC, D ;
TURLIN, B ;
SEARLE, J ;
BRISSOT, P ;
POWELL, LW ;
HALLIDAY, JW .
HEPATOLOGY, 1993, 18 (06) :1363-1369
[8]   PRIMARY LIVER-CANCER IN GENETIC HEMOCHROMATOSIS - A CLINICAL, PATHOLOGICAL, AND PATHOGENETIC STUDY OF 54 CASES [J].
DEUGNIER, YM ;
GUYADER, D ;
CRANTOCK, L ;
LOPEZ, JM ;
TURLIN, B ;
YAOUANQ, J ;
JOUANOLLE, H ;
CAMPION, JP ;
LAUNOIS, B ;
HALLIDAY, JW ;
POWELL, LW ;
BRISSOT, P .
GASTROENTEROLOGY, 1993, 104 (01) :228-234
[9]  
EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO
[10]  
2-E